Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 3,124 shares at $48.81 ($153K) on 2022-02-23, disclosed to the SEC on 2022-02-23.
Open-market sale of $153k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.81 | 1,211 | $59K | 38.6% |
| 2 | $48.81 | 1,211 | $59K | 38.6% |
| 3 | $49.59 | 702 | $35K | 22.7% |
| Total | $48.99 avg | 3,124 | $153K | 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |